MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its gr

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the p

Pediatrix Medical Group (NYSE:MD) held its second-quarter earnings conference call on Tuesday. Below

Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'

Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.63 per share which beat the anal

Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading pr

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold